The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $33.44

Today's change-0.55 -1.62%
Updated September 29 3:39 PM EDT. Delayed by at least 15 minutes.
 

Pfizer Inc

NYSE: PFE
Last

(U.S.) $33.44

Today's change-0.55 -1.62%
Updated September 29 3:39 PM EDT. Delayed by at least 15 minutes.

Pfizer Inc down (U.S.)$0.55

Pfizer Inc is sharply lower today, dropping (U.S.)$0.55 or 1.62% to (U.S.)$33.44. Shares have lost 2.08% over the last five days, but have gained 3.59% over the last year to date. This security has underperformed the S&P 500 by 6.70% during the last year.

Key company metrics

  • Open(U.S.) $33.94
  • Previous close(U.S.) $33.99
  • High(U.S.) $34.07
  • Low(U.S.) $33.30
  • Bid / Ask(U.S.) $33.43 / (U.S.) $33.44
  • YTD % change+3.59%
  • Volume17,805,881
  • Average volume (10-day)18,279,982
  • Average volume (1-month)18,340,383
  • Average volume (3-month)21,138,063
  • 52-week range(U.S.) $28.25 to (U.S.) $37.39
  • Beta0.86
  • Trailing P/E29.68×
  • P/E 1 year forward13.82×
  • Forward PEG2.12×
  • Indicated annual dividend(U.S.) $1.20
  • Dividend yield3.59%
  • Trailing EPS(U.S.) $1.13
Updated September 29 3:39 PM EDT. Delayed by at least 15 minutes.
S&P TSX0.20%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2016Q1/2016Q4/2015Q3/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJul 03, 201607/03/2016Apr 03, 201604/03/2016Dec 31, 201512/31/2015Sep 27, 201509/27/2015
Revenue13,14713,00514,04712,087
Total other revenue--------
Total revenue13,14713,00514,04712,087
Gross profit9,97310,15410,6759,880
Total cost of revenue3,1742,8513,3722,207
Total operating expense10,5479,23414,0799,218
Selling / general / administrative3,4713,3855,0483,270
Research & development1,7481,7312,3481,722
Depreciation / amortization9611,006980937
Interest expense (income), net operating--------
Unusual expense (income)1,4535971,5571,286
Other operating expenses, total-260-336774-204
Operating income2,6003,771-322,869
Interest income (expense), net non-operating-308-321-335-278
Gain (loss) on sale of assets319235
Other--------
Income before tax2,4103,561-3552,697
Income after tax2,0353,026-1672,130
Income tax, total375535-188567
Net income2,0203,017-1732,129
Total adjustments to net income-1-111
Net income before extra. items2,0193,017-1702,121
Minority interest-16-9-3-9
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items2,0183,016-1692,122
Inc. avail. to common incl. extra. items2,0193,016-1722,130
Diluted net income2,0193,016-1722,130
Dilution adjustment00--0
Diluted weighted average shares6,1376,2146,1766,243
Diluted EPS excluding extraordinary itemsvalue per share0.330.49-0.030.34
Dividends per sharevalue per share0.300.300.280.28
Diluted normalized EPSvalue per share0.550.600.210.51